DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Share Buyback
CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 treasury shares
25-Feb-2021 / 20:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
=----------------------------------------------------------------------------------------------------------------------
The general partner of CompuGroup Medical SE & Co. KGaA (the "Company") (ISIN: DE000A288904 | WKN: A28890), utilising
the authorization granted by its annual general meeting of May 15, 2019 and pursuant to section 71(1) no. 8 of the
German Stock Corporation Act (Aktiengesetz), resolved today to buy back a maximum number of up to 500,000 shares of the
Company (corresponding to approx. 0.93% of the Company's share capital) at a maximum purchase price (excluding
transaction costs) of up to EUR 40,000,000.00 in total (the "Share Buy-back Program").
The Share Buy-back Program will be carried out by a credit institution. The credit institution will acquire the shares
on the stock market and will decide on the timing of acquisition independently of the Company in accordance with the
safe harbor provisions of Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16
April 2014 (Market Abuse Regulation) in conjunction with the Commission Delegated Regulation (EU) 2016/1052 of 8 March
2016. In addition, the purchase price per share (excluding transaction costs) paid must not exceed, or fall short of,
the volume-weighted average price of the Company's share in XETRA trading on the Frankfurt Stock Exchange during the
last five trading days before the acquisition date by more than 10%.
Shares will be bought back in the period from February 26, 2021 to and including April 30, 2021. The Company's treasury
shares acquired by means of the Share Buy-back Program are to be used for the purposes permitted under the
authorization granted by the annual general meeting of May 15, 2019.
Further details will be published separately by the Company prior to the start of the share buy-back.
=----------------------------------------------------------------------------------------------------------------------
25-Feb-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and
Press Releases.
Archive at www.dgap.de
=----------------------------------------------------------------------------------------------------------------------
Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1171325
End of Announcement DGAP News Service
=------------ 1171325 25-Feb-2021 CET/CEST
(END) Dow Jones Newswires
February 25, 2021 14:02 ET (19:02 GMT)
